Gastric Neuroendocrine Tumors (Carcinoids)

AbstractPurpose of ReviewThe diagnosis of gastric neuroendocrine tumors (NETs) is being made with increased frequency likely as a result of more upper endoscopies being done for unrelated reasons. It is therefore vital that gastroenterologists become familiar with the basic work-up and management of patients found to have these tumors. This review describes the classification, pathophysiology, clinical characteristics, and treatment options of the different gastric NETs.Recent FindingsIn addition to the three traditional subtypes of gastric NETs, additional cases associated with achlorhydria and appropriate hypergastrinemia may exist. The management of gastric NETs between 1 and 2  cm in size remains controversial and needs to be individualized.SummaryGastric NETs are uncommon but are now diagnosed more frequently. This review highlights the role of hypergastrinemia in their development and the controversies around their management.

Source: Current Gastroenterology Reports - March 11, 2019 Category: Gastroenterology Source Type: research